Patricia Rich, MD, a board-certified and fellowship-trained medical oncologist, has rejoined the medical staff at Cancer Treatment Centers of America® (CTCA), Atlanta.
Dr. Rich has expertise in treating lung and head and neck cancers, with additional experience in treating sarcomas, melanoma breast and prostate cancers. Her career with CTCA includes serving patients at the Chicago and Atlanta hospitals, serving most recently as a medical oncologist and director of the Lung Cancer Center at CTCA Atlanta from 2013 to 2020. She also helped Piedmont Oncology build its thoracic oncology program.
Dr. Rich earned her medical degree from the University of Miami, Leonard M. Miller School of Medicine in Miami, Fla., and completed her residency in internal medicine at University of Miami, Jackson Memorial Hospital in Miami, Fla. She also completed a fellowship in hematology and oncology from the University of South Florida, H. Lee Moffitt Cancer Center & Research Institute in Tampa, Fla.
“Dr. Rich will bring instant impact to our hospital,” said Dr. Jeffrey Metts, chief of staff at CTCA Atlanta, now part of City of Hope. “Her career combines treating some very complex cancer types with compassionate care. She embodies the heart of CTCA.”
“Growing up in Argentina, I discovered my passion for medicine early in life helping my family administer polio vaccines to impoverished neighborhoods,” Dr. Rich said. “Caring for people is my calling, and I’m excited for new opportunities within an empowering healthcare environment.”
An active, published clinical researcher, Dr. Rich has also served on the Georgia Leadership Board of the American Lung Association and American Lung Association’s Lung Cancer Expert Medical Advisory Panel, which provides the association with strategic advice on critical lung cancer science and lung cancer-related issues.
About Cancer Treatment Centers of America
Cancer Treatment Centers of America (CTCA), part of City of Hope, is a national network of oncology hospitals and outpatient care centers offering an integrated approach that combines surgery, radiation, chemotherapy, immunotherapy and advancements in precision medicine with supportive therapies to manage side effects and enhance quality of life during treatment and into survivorship. CTCA publishes treatment results biannually, including patient experience, length of life, quality of life, patient safety and quality of care. CTCA also offers qualified patients a range of clinical trials that may reveal new treatment options supported by scientific and investigational research. CTCA patient satisfaction scores consistently rank among the highest for all cancer care providers in the country. For more information, follow us on Facebook, Twitter, Instagram or LinkedIn.
City of Hope’s mission is to deliver the cures of tomorrow to the people who need them today. Founded in 1913, City of Hope has grown into one the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. As an independent, National Cancer Institute (NCI)-designated comprehensive cancer center, City of Hope reflects a uniquely integrated model spanning cancer care, research and development, academics and training, and innovation initiatives. For more information about City of Hope, follow us on Facebook, Twitter, YouTube, Instagram, or LinkedIn.